Uni-Bio Science Group Limited
UNBSF
$0.004
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.78% | 9.71% | -3.97% | -3.78% | 27.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.78% | 9.71% | -3.97% | -3.78% | 27.91% |
| Cost of Revenue | -15.53% | -15.58% | -24.83% | -24.68% | 0.11% |
| Gross Profit | 16.28% | 16.21% | 1.99% | 2.19% | 37.73% |
| SG&A Expenses | -5.74% | -5.79% | -7.33% | -7.14% | 37.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 55.45% | 55.46% | -998.24% | -1,000.00% | 0.12% |
| Total Operating Expenses | -1.82% | -1.88% | -8.09% | -7.91% | 16.08% |
| Operating Income | 64.32% | 64.22% | 26.24% | 26.50% | 145.71% |
| Income Before Tax | 65.32% | 65.22% | 16.22% | 16.45% | 184.08% |
| Income Tax Expenses | 4.48% | 4.40% | -75.01% | -74.96% | 515.22% |
| Earnings from Continuing Operations | 71.49% | 71.38% | 31.98% | 32.24% | 169.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.49% | 71.38% | 31.98% | 32.24% | 169.38% |
| EBIT | 64.32% | 64.22% | 26.24% | 26.50% | 145.71% |
| EBITDA | 63.73% | 63.63% | 37.75% | 38.03% | 75.72% |
| EPS Basic | 75.00% | 75.00% | 50.00% | 50.00% | 300.00% |
| Normalized Basic EPS | 66.67% | 66.67% | 0.00% | 0.00% | 200.00% |
| EPS Diluted | 75.00% | 75.00% | 50.00% | 50.00% | 300.00% |
| Normalized Diluted EPS | 66.67% | 66.67% | 0.00% | 0.00% | 200.00% |
| Average Basic Shares Outstanding | -3.16% | -3.16% | 0.13% | 0.13% | 0.16% |
| Average Diluted Shares Outstanding | -3.16% | -3.16% | 0.13% | 0.13% | 0.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |